Organometallics
Article
days, colorless crystals were formed, which were washed gently with a
small amount of cold hexane. Crystallization from toluene yielded
trans-[Pt{B(Br)(tBu)}(μ-Br)(PCy3)]2 (126 mg, 89.8 μmol, 73%).
1H NMR (500.13 MHz, CD2Cl2, 297.6 K): δ 2.14−2.07 (m, 6H,
Cy), 1.85−1.82 (m, 6H, Cy), 1.72−1.65 (m, 9H, Cy), 1.34−1.24 (m,
12H, Cy), 1.21 (s, 9H, tBu). 11B{1H} NMR (160.46 MHz, CD2Cl2,
298.1 K): δ 68.7 (ω ≈ 1700 Hz). 13C{1H} NMR (100.61 MHz,
CD2Cl2, 296.2 K): δ 35.9 (d, 1JC−P = 31 Hz, C1 Cy); 30.3 (br s, Ci tBu,
systems by analysis of the topology of the electron density in
the fully relaxed geometry optimizations.
A T-shaped cationic complex with reduced steric bulk at the
phosphine substituents, compared to its tricyclohexylphosphine
derivative, was fully characterized.
EXPERIMENTAL SECTION
■
3
C3,5 Cy), 29.6 (d, JC−P = 11 Hz, C3,5 Cy), 26.6 (s, C4 Cy). 31P{1H}
All manipulations were conducted either under an atmosphere of dry
argon or in vacuo using standard Schlenk line or glovebox techniques.
[Pt(PCy3)2],32 [Pt(PiPr3)3],33 Na[BArf4],34 BBr2tBu,35 BBr2Mes,36
and BBr2Fc37 were prepared according to published procedures. BCl3
was purchased from GHC Gehrling, Holz + Co and used as received.
BBr3 was purchased from Acros Organics and stirred over Hg prior to
use.
NMR (202.46 MHz, CD2Cl2, 298.0 K): δ 28.2 (1JP−Pt = 4740 Hz).
Anal. Calcd (%) for C44H84B2Br2P2Pt2: C 37.57, H, 6.02. Found: C
38.15, H 5.98.
Synthesis of trans-[Pt(BMes)Br(PCy3)2][BBr4] (12). A solution
of freshly prepared trans-[Pt(BBrMes)Br(PCy3)2] (27.7 mg, 26.1
μmol) was mixed with a solution of BBr3 in C6D6 (0.3 mL, 0.1 M, 30.0
μmol). Within a few minutes, colorless crystals of trans-[Pt(BMes)-
Br(PCy3)2][BBr4] were formed (22.0 mg, 17.0 μmol, 65%).
1H NMR (400.13 MHz, CD2Cl2, 296.1 K): δ 7.05 (s, 2H, Mes),
2.79 (m, 6H, Cy), 2.74 (s, 6H, Meo, Mes), 2.39 (s, 3H, Mep, Mes),
2.05−2.00 (m, 12H, Cy), 1.79−1.61 (m, 30H, Cy), 1.10−1.07 (m,
18H, Cy). 11B{1H} NMR (128.39 MHz, CD2Cl2, 296.1 K): δ −24.5
(s, BBr4). 13C{1H} NMR (100.61 MHz, CD2Cl2, 296.5 K): δ 151.0 (s,
Cp, Mes), 147.1 (s, Co, Mes), 132.0 (br s, Ci, Mes), 130.2 (m, Cm,
Solvents were dried according to standard procedures, degassed,
and stored under argon over activated molecular sieves. C6D6 and
CD2Cl2 were degassed by three freeze−pump−thaw cycles and stored
over molecular sieves. Reagents were dried and purified by standard
procedures. NMR spectra were acquired on a Bruker AMX 400 or a
Bruker Avance 500 NMR spectrometer. Chemical shifts are given in
ppm and are referenced against external Me4Si (1H, 13C), BF3·Et2O
(11B), and H3PO4 (85%, 31P). Assignments were made from the
analysis of 1H,13C-HMQC and 1H,13C-HMBC NMR spectroscopic
experiments. Microanalyses (C, H, N) were performed on a Leco
Instruments elemental analyzer, type CHNS 932.
3
Mes), 37.5 (vt, N = |1JP−C + JP−C| = 28 Hz, C1, Cy); 30.6 (m, C3,5,
Cy), 27.8 (vt, N = |1JP−C + 3JP−C| = 11 Hz, C2,6, Cy), 26.5 (s, C4, Cy),
23.3 (s, Meo, Mes), 22.7 (s, Mep, Mes). 31P{1H} NMR (161.98 MHz,
CD2Cl2, 296.5 K): δ 45.0 (1JP−Pt = 2073 Hz). Anal. Calcd (%) for
C45H77B2Br5P2Pt: C 41.70, H 5.99. Found: C 41.10, H 6.21.
Synthesis of trans-[Pt(BCl2)Cl(PCy3)2] (15). Solid [Pt(PCy3)2]
(201 mg, 265 μmol) was dissolved in 2 mL of toluene and cooled to
−78 °C. Addition of a BCl3 solution in toluene (2 M, 0.14 mL, 280
μmol) led to the formation of a colorless suspension. The mixture was
heated until all solids were dissolved. Slow cooling to ambient
temperature yields trans-[Pt(BCl2)Cl(PCy3)2] as a colorless solid (168
mg, 192 μmol, 72%).
Synthesis of trans-[Pt{B(Br)(NMe2)}(NCMe)(PCy3)2][BArf4] (3).
Addition of MeCN (1.0 mg, 24.4 μmol) to a light yellow solution of
trans-[Pt{B(Br)(NMe2)}(PCy3)2][BArf4] (30.0 mg, 17.1 μmol) in
CD2Cl2 (0.5 mL) led to the formation of a nearly colorless solution of
trans-[Pt{B(Br)(NMe2)}(NCMe)(PCy3)2][BArf4]. Layering the sol-
ution with a few drops of hexane and cooling to −35 °C yielded
colorless crystals (25.0 mg, 13.9 μmol, 82%).
1H NMR (400.13 MHz, CD2Cl2, 296.3 K): δ 7.73 (m, 8H, BArf4),
7.56 (br s, 4H, BArf4), 3.18 (s, 3H, NMe2), 2.89 (s, 3H, NMe2), 2.33−
2.27 (m, 6H, Cy), 2.17 (s, 3H, NCMe), 2.02−1.99 (m, 6H Cy), 1.90−
1.85 (m, 18H, Cy), 1.78−1.75 (m, 6H, Cy), 1.67−1.51 (m, 12H, Cy),
1.31−1.21 (m, 20H, Cy). 11B{1H} NMR (128.38 MHz, CD2Cl2, 296.4
K): δ 25.0 (br s), −6.7. 13C{1H} NMR (100.61 MHz, CD2Cl2, 196.2
1H NMR (400.13 MHz, CD2Cl2, 297.2 K): δ 2.49 (m, 6H, Cy),
2.03 (m, 12H, Cy), 1.81 (m, 12H, Cy), 1.70 (m, 18H, Cy), 1.25 (m,
18H, Cy). 11B{1H} NMR (160.46 MHz, CD2Cl2, 297.2 K): δ 59.0 (br
s, ω1/2 ≈ 1500 Hz). 13C{1H} NMR (100.61 MHz, CD2Cl2, 297.2 K): δ
35.4 (m, C1, Cy), 30.4 (m,C3,5, Cy), 28.0 (m, C2,6, Cy), 26.9 (m, C4,
Cy). 31P{1H} NMR (161.98 MHz, CD2Cl2, 297.2 K): δ 24.2 (s, 1JP−Pt
= 2675 Hz). Anal. Calcd (%) for C36H66BCl3P2Pt: C 49.52, H 7.62.
Found: C 49.42, H 7.64.
1
K): δ 162.1 (q, Ci, JC−B = 50 Hz), 135.2 (s, Co, BArf4), 129.2 (br q,
2JC−F = 32 Hz Cm, BArf4), 125.0 (q, 1JC−F = 272 Hz, CF3, BArf4), 117.7
(br s, Cp, BArf4). 47.2 (s, NMe2), 41.1 (s, NMe2), 35.5 (vt, N = |1JP−C
+ 3JP−C| = 27 Hz, C1, Cy), 30.8 (m, C3,5, Cy), 28.0 (m, C2,6, Cy), 26.5
(s, C4, Cy), 2.9 (s, MeCN). 19F{1H} NMR (376.50 MHz, CD2Cl2,
296.3 K): δ −62.9. 31P{1H} NMR (161.98 MHz, CD2Cl2, 296.1 K): δ
32.9 (s, 1JP−Pt = 2786 Hz). Anal. Calcd (%) for C72H87B2BrF24N2P2Pt:
C 48.18, H 4.98, N 1.56. Found: C 48.68, H 4.93, N 1.51.
Synthesis of trans-[Pt(BCl2)(PCy3)2][BArf4] (13). Solid trans-
[Pt(BCl2)Cl(PCy3)2] (15) (50.0 mg, 0.057 mmol) and Na[BArf4]
(50.8 mg, 57.3 μmol) are mixed in CD2Cl2. The reaction mixture
immediately turns yellow, and a colorless solid precipitates, which is
filtered off. Layering the solution with hexane and cooling to −35 °C
yields colorless crystals (52.0 mg, 30.6 μmol, 53%).
Synthesis of trans-[Pt{B(Br)(NMe2)}(NCMe)(PCy3)2]2[B12Cl12]
(6). Addition of Na2[B12Cl12] (31.0 mg, 51.6 μmol) to a solution of
trans-[Pt{B(Br)(NMe2)}Br(PCy3)2] (100 mg, 103 μmol) in (0.5 mL)
CD2Cl2 and one drop of MeCN, sonication, and filtering off the
precipitated colorless solid led to the formation of a nearly colorless
solution of trans-[Pt{B(Br)(NMe2)}(NCMe)(PCy3)2]2[B12Cl12].
Layering the solution with a few drops of hexane and cooling to
−35 °C led to the formation of colorless crystals (88.0 mg, 72.8 μmol,
73%).
1H NMR (500.13 MHz, CD2Cl2, 297.2 K): δ 7.73 (m, 8H, BArf4),
7.57 (br s, 4H, BArf4), 2.34 (m, 6H, Cy), 2.91 (m, 24H, Cy), 1.80 (m,
6H, Cy), 1.61 (m, 12H, Cy), 1.33 (m, 18H, Cy). 11B{1H} NMR
(160.46 MHz, CD2Cl2, 297.2 K): δ −7.6 (s, BArf4). 13C{1H} NMR
1
(125.76 MHz, CD2Cl2, 297.2 K): δ 162.2 (q, JC−B = 49.9 Hz, Ci,
2
3
BArf4), 135.2 (s, Co, BArf4), 129.3 (qq, JC−F = 31.4 Hz, JC−B = 3.17
Hz, Cm, BArf4), 125.0 (q, JC−F = 272 Hz, CF3, BArf4), 117.9 (sep,
1
3JC−F = 4.2 Hz, Cp, BArf4), 35.1 (m, C1, Cy), 30.4 (s, C3,5, Cy), 27.4
1H NMR (400.13 MHz, CD2Cl2, 296.3 K): δ 3.17 (s, 3H, NMe2),
2.90 (s, 3H, NMe2), 2.44 (s, 3H, NCMe), 2.32−2.26 (m, 6H, Cy),
2.00−1.78 (m, 30H, Cy), 1.70−1.62 (m, 6H, Cy), 1.57−1.49 (m, 6H,
Cy), 1.34−1.21 (m, 18H, Cy). 11B{1H} NMR (128.38 MHz, CD2Cl2,
296.2 K): δ 24.4 (br s), −12.9 (s, B12Cl12). 13C{1H} NMR (100.61
MHz, CD2Cl2, 296.2 K): 124.1 (s, MeCN), 47.5 (s, NMe2), 41.2 (s,
(m, C2,6, Cy), 26.1 (s, C4, Cy). 31P{1H} NMR (202.46 MHz, CD2Cl2,
1
297.2 K): δ 43.5 (br s, JP−Pt = 2657 Hz). Anal. Calcd (%) for
C68H78B2Cl2F24P2Pt: C 48.02, H 4.62. Found: C 48.21, H 4.79.
Synthesis of trans-[Pt{B(Br)(Fc)}Br(PiPr3)2] (17). Addition of a
solution of BBr2Fc (280 mg, 767 μmol) in toluene (2 mL) to a freshly
prepared solution of [Pt(PiPr3)2] (396 mg, 767 μmol) in toluene (3
mL) results in a light red solution. Cooling of the reaction mixture to
−65 °C overnight led to the formation of a red solid, which was
separated and washed gently with 2 mL of cold hexane (474 mg, 545
μmol, 71%). Single crystals were obtained by crystallization from
dichloromethane at −35 °C.
3
NMe2), 35.5 (vt, N = |1JP−C + JP−C| = 27 Hz, C1, Cy), 30.9 (m, C3,5,
Cy), 28.1 (m, C2,6, Cy), 26.7 (s, C4, Cy), 4.2 (s, MeCN). 31P{1H}
1
NMR (161.98 MHz, CD2Cl2, 296.1 K): δ 28.8 (br s, JP−Pt = 2778
Hz). Anal. Calcd (%) for C80H150B14Br2Cl12N4P4Pt2: C 39.73, H 6.25,
N 2.32. Found: C 40.19, H 6.18, N 2.27.
Synthesis of trans-[Pt{B(Br)(tBu)}(μ-Br)(PCy3)]2 (8). A yellowish
mixture of BBr2tBu (140 mg, 615 μmol) and [Pt(PCy3)2] (186 mg,
246 μmol) in C6D6 (0.5 mL) was heated to 50 °C for 5 h. After 11
1H NMR (500.13 MHz, C6D6, 297.2 K): δ 4.74 (m, 2H, Cp), 4.26
(m, 2H, Cp), 4.09 (s, 5H, Cp), 2.94 (m, 6H, CH), 1.35 (m, 18H, CH3,
1905
dx.doi.org/10.1021/om2012248 | Organometallics 2012, 31, 1897−1907